August 25, 2010
Bioniche & University of Ottawa Sign Exclusive Global License Agreement for Natural Health Technology

August 20, 2010
Additional Phase III Clinical Trial with UrocidinTM Expected to Commence in 2010

Check latest
stock price

All prices delayed at least 15 minutes.
Source: TSX Inc.

Products in Development

Human Health

Bioniche has developed a technology for the treatment of human cancers. The first product developed from this technology is Urocidin^TM, a formulation of Mycobacterial Cell Wall-DNA Complex (MCC) for the treatment of bladder cancer. A Phase III clinical program is underway, in partnership with Endo Pharmaceuticals Inc.

For more information about the Company’s clinical programs, please contact Bioniche Therapeutics at clinicaltrials@bioniche.com

Marketed Products

Animal Health Products

Information about Bioniche Animal Health products can be found at www.bionicheanimalhealth.com

Food Safety Products

EconicheTM is the first marketed product of the Bioniche Food Safety division.

Contact Bioniche Food Safety